Dosimetric predictors of acute hematologic toxicity due to intensity-modulated pelvic radiotherapy with concurrent chemotherapy for pelvic cancer patients

Background: null Hematologic toxicity is a major common side effect after chemoradiotherapy in pelvic cancer patients. Here, we investigate the clinical and dosimetric factors associated with acute hematologic toxicity in Chinese cervical and rectal cancer patients treated with pelvic intensity-modulated radiotherapy with concurrent chemotherapy. null Methods: null We retrospectively analyzed 171 patients receiving concurrent chemoradiotherapy...